Genus plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genus plc with three other
miscellaneous service companies in Europe:
sales of £384.40 million [US$494.09 million]
of which 70%
was Technical Consulting),
Clipper Logistics PLC
(£460.17 million [US$591.48 million]
of which 82%
was Value-added Logistics Services), and
Clinigen Group PLC
(£456.90 million [US$587.28 million]
of which 45%
was Unlicensed Medicines).
During the year ended June of 2019, sales at
Genus plc were £488.50 million (US$627.89 million).
increase of 3.9%
versus 2018, when the company's sales were £470.30 million.
This was the third consecutive year of growth at Genus plc.
Sales of Operating Bovine Products Development saw an increase
that was more than double the company's growth rate: sales were up
27.3% in 2019, from
£2.20 million to £2.80 million.
Genus plc also saw significant increases in sales in
Operating Genus Abs (up 5.7% to £222.60 million)
Not all segments of Genus plc experienced an increase in sales in 2019:
sales of Operating Porcine Products Development fell 4.1% to £9.40 million.
(However, this segment's sales were only a very small portion of the company's overall sales).